These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7137036

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds.
    Hellestrand KJ, Nathan AW, Bexton RS, Camm AJ.
    Am J Cardiol; 1984 Feb 27; 53(5):30B-38B. PubMed ID: 6695817
    [Abstract] [Full Text] [Related]

  • 3. Electrophysiologic properties of flecainide acetate.
    Estes NA, Garan H, Ruskin JN.
    Am J Cardiol; 1984 Feb 27; 53(5):26B-29B. PubMed ID: 6695816
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Electrophysiologic effects of flecainide acetate and its major metabolites in the canine heart.
    Guehler J, Gornick CC, Tobler HG, Almquist A, Schmid JR, Benson DW, Benditt DG.
    Am J Cardiol; 1985 Mar 01; 55(6):807-12. PubMed ID: 3919554
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
    Nathan AW, Hellestrand KJ, Bexton RS, Banim SO, Spurrell RA, Camm AJ.
    Am Heart J; 1984 Feb 01; 107(2):222-8. PubMed ID: 6695656
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V, Ickrath O, Schmid F, Mayer F, Haasis R, Seipel L.
    Z Kardiol; 1989 Oct 01; 78(10):640-6. PubMed ID: 2686251
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Electrophysiologic effects of cibenzoline in humans related to dose and plasma concentration.
    Touboul P, Atallah G, Kirkorian G, de Zuloaga C, Dufour A, Aymard MF, Lavaud P, Moleur P.
    Am Heart J; 1986 Aug 01; 112(2):333-9. PubMed ID: 3526853
    [Abstract] [Full Text] [Related]

  • 19. Electrophysiologic effects of disopyramide in patients with atrioventricular nodal dysfunction.
    Wilkinson PR, Desai J, Hollister J, Gonzalez R, Abbott JA, Scheinman MM.
    Circulation; 1982 Dec 01; 66(6):1211-6. PubMed ID: 7139899
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.